Navigation Links
Antiviral lipid earns patent
Date:3/5/2013

Dennis Voelker, PhD, professor of medicine at National Jewish Health, has been awarded a U.S. patent (#8,367,643) for various lipids and related compounds that can inhibit inflammation and infection in the lungs, especially those caused by influenza and respiratory syncytial virus (RSV). Over the past several years, Dr. Voelker has published several scientific papers describing a naturally occurring lipid in the lungs, POPG (palmitoyl-oleoyl-phosphatidylglycerol), that reduces inflammation and inhibits infection by the influenza virus and RSV. The patent covers POPG and other naturally occurring lipids in the lungs as well as related anionic lipids.

"POPG and related compounds offer a promising approach for the prevention and treatment of influenza and other respiratory virus infections," said Dr. Voelker. "We are thrilled to earn this patent, so that we can push this work forward toward clinical application."

POPG is one of several lipids in the fluid that lines the air sacs of the lungs. Other lipids and proteins in this surfactant fluid are known to prevent collapse of the air sacs and to contribute to innate immunity. Only recently have Dr. Voelker and his colleagues discovered POPG's anti-inflammatory function and its ability to inhibit viral infection.

"Lipids such as POPG, offer potential advantages over antiviral proteins, because they are less likely to elicit unwanted immune responses, are more chemically stable, and less expensive to manufacture than proteins," said Dr. Voelker.


'/>"/>

Contact: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Source:Eurekalert

Page: 1

Related biology news :

1. Felix Goñi, Avanti award for best European research in lipids
2. UI researcher learns mechanism of hearing is similar to car battery
3. Plan to turn farm waste into paper earns students $15,000
4. Louisiana Tech University professor earns national honor from Society of American Foresters
5. American Society for Microbiologys newest journal earns a high impact factor in latest rankings
6. Florida Tech biological sciences professor earns $257,000 NSF grant to study coral diseases
7. LaserLock Technologies Files for Provisional Patent Enabling Mobile Phones with Anti-Counterfeiting Technology
8. Celladon Corporation Receives Notice of Allowance from United States Patent and Trademark Office
9. Texas Biomed files patent for a novel HIV vaccine strategy
10. USDA patents method to reduce ammonia emissions
11. Aware Announces Closing Of Sale Of Selected Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the ... the Dow Jones Industrial Average edged 0.27% lower to finish ... 0.17%. Stock-Callers.com has initiated coverage on the following equities: Infinity ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... ). Learn more about these stocks by accessing their free ...
Breaking Biology Technology: